YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Medtronic Pacemakers
Medtronic Pacemakers
Medtronic Inc. announced they are advising physicians of a potential problem in a small number of its Sigma pacemakers in which wires may separate from a circuit. No deaths or injuries were reported, though some users suffered dizziness or fainting, according to the Fridley-based medical-devices maker. An estimated 28,000 pacemakers, including 6,650 in the U.S., are covered by the advisory, which Medtronic said could be classified by the U.S. Food and Drug Administration as a recall.Medtronic said the defect took place when a solvent used to clean pacemaker wires degraded them over time, causing the wires to break from the circuitry in 19 devices. Pacemakers help spark the heart to achieve a steady, timely beat. The company estimates that 47 to 84 units, all made between November 2001 and August 2004, could be affected over the 10-year life of the units.
"The risk to patients is extremely low, but we are alerting physicians to the issue to ensure they are aware of the situation and can appropriately care for their patients," said Steve Mahle, president of Medtronic's cardiac rhythm management division.
Although the company doesn't recommend replacing the devices "prior to normal elective replacement,'' it added that this decision should be left up to the doctor based on each patients unique circumstances.
If you or a loved one suffered injuries from a Medtronic Pacemaker, please fill out the form at the right for a free case evaluation by a qualified defective medical device attorney.
Medtronic PacemakersRSS Feed
Medtronic Cardiac Rhythm Disease Management Site Gets FDA Warning Letter
Nov 19, 2009 | Parker Waichman Alonso LLP
Device maker giant, Medtronic, Inc., just announced that it received a warning letter from the U.S. Food & Drug Administration (FDA).According to the Twin Cities Business Journal, the letter came after an inspection of Medtronic’s Mounds View Cardiac Rhythm Disease Management site and concerned: “Corrective and preventative action and field-action timeliness, review and documentation of field action recommendations, supplier qualification and controls, and medical-device...
Grassley Putting More Heat on Spine Surgeon with Medtronic Ties
Sep 23, 2009 | Parker Waichman Alonso LLP
Senator Charles Grassley (R-Iowa) has expanded his investigation of Dr. David Polly. As we've reported previously, the relationship between Dr. Polly, head of spine surgery at the University of Minnesota, and Medtronic Inc. has been under scrutiny.Grassley's probe of Dr. Polly has already revealed that he had been paid $1.2 million by Medtronic between 2003 and 2007 for consulting work. Dr. Polly had come under fire in July for not disclosing his relationship with Medtronic...
Medtronic Advisory Says Some Concerto, Virtuoso Defibrillator Batteries May Deplete Prematurely
Sep 11, 2009 | Parker Waichman Alonso LLP
Medtronic Inc. has issued an advisory for 6,300 Concerto CRT-D and Virtuoso implantable defibrillators. According to the advisory, the batteries on these devices may be depleted sooner than normalAccording to a letter sent to physicians, the devices affected by this advisory will give a 90-day advanced warning if the batteries are nearing depletion. Medtronic maintains that the battery issue does not compromise device functionality or affect therapy delivery. The company said...
Lawsuits Allege Medtronic, Other Firms Illegally Marketed Surgical Ablation Products
Jul 16, 2009 | Parker Waichman Alonso LLP
Medtronic Inc., St. Jude Medical Inc., AtriCure Inc. and Boston Scientific Corp. all allegedly paid kickbacks to doctors in order to convince them to use their surgical ablation products to treat the heart-rhythm defect called atrial fibrillation, according to lawsuits recently unsealed in Texas. According to The Wall Street Journal, the lawsuits were filed by former employees of the companies.Allegations of kickbacks by medical device makers are nothing new. For example, in...
Medtronic Warned on SynchroMed Drug Pumps, MiniMed Insulin Pump Manufacturing
Jun 25, 2009 | Parker Waichman Alonso LLP
Medtronic Inc. has received a warning letter regarding its SynchroMed II Drug Pumps and MiniMed Paradigm Insulin Pump. In the letter, the Food & Administration (FDA), cites Medtronic for taking too long to recall the SynchroMed pumps. The letter also said that an inspection conducted last year at the Puerto Rican plant where both pumps were made found that Medtronic failed to establish and maintain quality controls in manufacturing.SynchroMed II pumps are...
Medtronic Pacemakers
Quick Facts
Medtronic Pacemakers Reference Guide
Manufacturer
Medtronic
Status
11/29/05 Advisory
Complications
Wires separate from circuit
Models Affected
April 2001 - December 2003
Marquis VR/DR
Maximo VR/DR
InSync I/II/III Marquis
InSync III Protect CRT-D
Related Topics
Guidant Pacemakers
Guidant Implantable Pacemaker
Defective Medical Devices
Medtronic
Status
11/29/05 Advisory
Complications
Wires separate from circuit
Models Affected
April 2001 - December 2003
Marquis VR/DR
Maximo VR/DR
InSync I/II/III Marquis
InSync III Protect CRT-D
Related Topics
Guidant Pacemakers
Guidant Implantable Pacemaker
Defective Medical Devices
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS